TRANSFUSION AND 2ND MALIGNANCY

被引：10

作者：

FORD, CD

GILLETTE, JW

HANDRAHAN, DL

KOEHLER, CS

机构：

[1] LATTER DAY ST HOSP,TUMOR REGISTRY,CANC PROGRAM,SALT LAKE CITY,UT 84143

[2] LATTER DAY ST HOSP,TUMOR REGISTRY,CTR STAT DATA,SALT LAKE CITY,UT 84143

来源：

TRANSFUSION | 1994年 / 34卷 / 01期

关键词：

D O I：

10.1046/j.1537-2995.1994.34194098607.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Perioperative blood transfusion has been reported to cause a variety of immunosuppressive effects, including increased rates of malignancy recurrence. The effect of perioperative transfusion on second malignancy risk has not previously been investigated. Study Design and Methods: Second malignancy risk was evaluated in 1053 patients previously operated upon for colon cancer, and these findings are related to perioperative transfusion history. Results: Transfusion history did not relate to the probability of a patient's remaining free of second malignancy. Conclusion: An increased risk of total or second malignancies (with the possible exception of lung cancer) was not associated with transfusion.

引用

页码：63 / 65

页数：3

共 12 条

[1] THE INDUCTION OF IMMUNOLOGICAL HYPORESPONSIVENESS BY PREOPERATIVE DONOR-SPECIFIC TRANSFUSIONS AND CYCLOSPORINE IN HUMAN CADAVERIC TRANSPLANTS - A PRELIMINARY TRIAL [J].